false EX-99.I.SBSEF XYZ 9876543210 9876543210 2023-01-01 2023-12-31 9876543210 2023-12-31 9876543210 2022-12-31 9876543210 2022-01-01 2022-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

Ex. I (Financials) Mockup 

THIS DOCUMENT IS A TECHNICAL ILLUSTRATION OF HOW CERTAIN DISCLOSURES IN SEC FILINGS ARE TO BE TAGGED. IT DOES NOT INDICATE WHICH PARTICULAR DISCLOSURES MUST BE INCLUDED AND/OR TAGGED IN COMMISSION FILINGS, AND IT DOES NOT CONSTITUTE LEGAL GUIDANCE OF ANY SORT.

Balance Sheet

 (in millions)  Dec. 31, 2023  Dec. 31, 2022
Assets      
Current Assets          
  Cash and cash equivalents  $570    280 
  Restricted cash  500    500 
  Prepaid expenses  500   500 
    Total current assets   1,570    1,280 
Equity method investments  20   20 
Right of use assets, operating lease  4   4 
Other assets  6    6 
Total Assets   1,600    1,310 
Liabilities and Stockholders' Equity          
 Current liabilities:          
   Accounts payable   400    400 
   Accrued expenses   8    8 
    Total current liabilities   408    408 
Lease obligations, operating   4    4 
Other liabilities   52    52 
Total Liabilities   464    464 
Common Stock   1    1 
Retained Earnings   1,135    845 
Total Stockholders' Equity   1,136    846 
Total Liabilities and Stockholders' Equity  $1,600    1,310 

 

Income and Expense Statement

   12 Months ended
Dec. 31, 2023
  12

Months ended

Dec. 31, 2022

Revenue   980    980 
Operating Expenses          
  Salary and associated benefits  $150    150 
  Professional services   100    100 
  Other expenses   500    500 
    Total Operating Expenses   750    750 
Other non-operating income   60    60 
Net Income  $290    290

 

Statement of Cash Flows

      12 Months ended
Dec. 31, 2023
         
Net income   $ 290        
Changes in other assets     0          
Net cash provided by operating activities     290      
Net cash provided by investing activities   0      
Net cash provided by financing activities   0      
Changes in cash, cash equivalents and restricted cash.   290     
Cash, cash equivalents and restricted cash, beginning of period   780      
Cash, cash equivalents and restricted cash, end of period  $1,070      

 

 

Sources and Application of Funds

   Dec. 31, 2023
Revenue  $980 
Other non-operating income   60 
 Total Operating expenses  $750 

 

Notes to the Financial Statements

1. Significant Accounting Policies. Ullamcorper morbi tincidunt ornare massa eget egestas purus. Lobortis elementum nibh tellus molestie. Aliquam purus sit amet luctus venenatis lectus magna fringilla urna. Feugiat scelerisque varius morbi enim nunc. Enim lobortis scelerisque fermentum dui faucibus in ornare quam viverra. Aliquam malesuada bibendum arcu vitae elementum curabitur vitae. Sagittis id consectetur purus ut faucibus. Egestas pretium aenean pharetra magna ac. Consequat mauris nunc congue nisi.

2. Cash and Cash Equivalents Disclosure. Nisl tincidunt eget nullam non. Sed velit dignissim sodales ut eu sem. Auctor neque vitae tempus quam pellentesque nec nam. Lorem sed risus ultricies tristique nulla aliquet enim. Quam pellentesque nec nam aliquam sem et tortor consequat. Tincidunt praesent semper feugiat nibh. Magna fermentum iaculis eu non diam. Facilisi etiam dignissim diam quis. Neque ornare aenean euismod elementum. Vel elit scelerisque mauris pellentesque pulvinar. Malesuada fames ac turpis egestas integer eget aliquet nibh. Vulputate eu scelerisque felis imperdiet.

We have enough assets for a year. Non pulvinar neque laoreet suspendisse interdum consectetur libero. Quis hendrerit dolor magna eget est lorem ipsum. Cras semper auctor neque vitae tempus quam pellentesque nec nam. Massa sapien faucibus et molestie ac feugiat sed lectus vestibulum. Sit amet consectetur adipiscing elit ut aliquam. Tincidunt lobortis feugiat vivamus at. Sit amet mauris commodo quis imperdiet massa tincidunt. Orci porta non pulvinar neque. Tempus quam pellentesque nec nam aliquam sem. Mollis aliquam ut porttitor leo. Ultrices mi tempus imperdiet nulla. At tempor commodo ullamcorper a lacus vestibulum. Eros in cursus turpis massa. Nibh ipsum consequat nisl vel pretium lectus quam. Id venenatis a condimentum vitae sapien pellentesque habitant morbi tristique. Eu ultrices vitae auctor eu augue ut. Ut etiam sit amet nisl purus in. Elit at imperdiet dui accumsan. Sodales neque sodales ut etiam sit amet nisl purus.

We have enough cash for six months.. Cras pulvinar mattis nunc sed blandit libero. Gravida quis blandit turpis cursus in hac habitasse. Aliquam etiam erat velit scelerisque in dictum non consectetur a. Vitae semper quis lectus nulla. Odio ut sem nulla pharetra diam sit amet nisl suscipit. Laoreet suspendisse interdum consectetur libero. Duis ut diam quam nulla porttitor. Nunc sed augue lacus viverra vitae congue eu consequat. Duis tristique sollicitudin nibh sit amet commodo nulla facilisi nullam. Malesuada pellentesque elit eget gravida cum. Pharetra magna ac placerat vestibulum lectus mauris ultrices eros in. Ullamcorper morbi tincidunt ornare massa eget egestas purus. Lobortis elementum nibh tellus molestie. Aliquam purus sit amet luctus venenatis lectus magna fringilla urna. Feugiat scelerisque varius morbi enim nunc. Enim lobortis scelerisque fermentum dui faucibus in ornare quam viverra. Aliquam malesuada bibendum arcu vitae elementum curabitur vitae. Sagittis id consectetur purus ut faucibus. Egestas pretium aenean pharetra magna ac. Consequat mauris nunc congue nisi.